The interplay between acute post-traumatic stress, depressive and anxiety symptoms on healthcare workers functioning during the COVID-19 emergency: A multicenter study comparing regions with increasing pandemic incidence.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 11 02 2021
revised: 30 07 2021
accepted: 20 10 2021
pubmed: 4 11 2021
medline: 15 12 2021
entrez: 3 11 2021
Statut: ppublish

Résumé

Healthcare workers (HCWs) deployed to the frontline during the COVID-19 pandemic are at risk for developing mental disorders, with a possible impact on their wellbeing and functioning. The present study aimed at investigating post-traumatic stress symptoms (PTSS), anxiety and depressive symptoms and their relationships with impairment in the functioning impairment among frontline HCWs from three Italian regions differently exposed to the first wave of the COVID-19 emergency: Tuscany (low), Emilia-Romagna (medium) and Lombardy (high). 514 frontline HCWs were consecutively enrolled in hospital units devoted to the treatment of COVID-19 patients. They completed the IES-R, PHQ-9 and GAD-7 to assess PTSS, depressive and anxiety symptoms respectively, and the WSAS to investigate functioning impairment. A total of 23.5% of HCWs reported severe PTSS, 22.4% moderate-severe anxiety symptoms, 19.3% moderate-severe depressive symptoms and 22.8% impairment in global functioning. HCWs from the higher-exposure regions reported significantly higher scores in all instruments than those from lower-exposure regions. In a multiple linear regression model, PTSS, depressive and anxiety symptoms presented a significant positive association with the functioning impairment. Both PTSS and depression resulted to be independently related to functioning impairment. The cross-sectional design and the use of self-report instruments. Depressive and PTSS appear to be the greatest contributors to functioning impairment in HCWs exposed to a massive stressful sanitary event as the COVID-19 pandemic. A more accurate assessment of work-related mental health outcomes in such population could help planning effective prevention strategies and therapeutic interventions.

Sections du résumé

BACKGROUND
Healthcare workers (HCWs) deployed to the frontline during the COVID-19 pandemic are at risk for developing mental disorders, with a possible impact on their wellbeing and functioning. The present study aimed at investigating post-traumatic stress symptoms (PTSS), anxiety and depressive symptoms and their relationships with impairment in the functioning impairment among frontline HCWs from three Italian regions differently exposed to the first wave of the COVID-19 emergency: Tuscany (low), Emilia-Romagna (medium) and Lombardy (high).
METHODS
514 frontline HCWs were consecutively enrolled in hospital units devoted to the treatment of COVID-19 patients. They completed the IES-R, PHQ-9 and GAD-7 to assess PTSS, depressive and anxiety symptoms respectively, and the WSAS to investigate functioning impairment.
RESULTS
A total of 23.5% of HCWs reported severe PTSS, 22.4% moderate-severe anxiety symptoms, 19.3% moderate-severe depressive symptoms and 22.8% impairment in global functioning. HCWs from the higher-exposure regions reported significantly higher scores in all instruments than those from lower-exposure regions. In a multiple linear regression model, PTSS, depressive and anxiety symptoms presented a significant positive association with the functioning impairment. Both PTSS and depression resulted to be independently related to functioning impairment.
LIMITATIONS
The cross-sectional design and the use of self-report instruments.
CONCLUSIONS
Depressive and PTSS appear to be the greatest contributors to functioning impairment in HCWs exposed to a massive stressful sanitary event as the COVID-19 pandemic. A more accurate assessment of work-related mental health outcomes in such population could help planning effective prevention strategies and therapeutic interventions.

Identifiants

pubmed: 34728285
pii: S0165-0327(21)01107-1
doi: 10.1016/j.jad.2021.10.128
pmc: PMC8556686
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

209-216

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

J Anxiety Disord. 2014 Aug;28(6):547-52
pubmed: 24983795
Ann Occup Environ Med. 2015 Jun 05;27:16
pubmed: 26137313
Emerg Med J. 2007 Jan;24(1):12-7
pubmed: 17183035
Workplace Health Saf. 2020 Jul;68(7):337-345
pubmed: 32146875
J Clin Psychiatry. 2008 Apr;69(4):597-602
pubmed: 18294026
Neuropsychiatr Dis Treat. 2018 Dec 24;15:115-125
pubmed: 30636877
Multivariate Behav Res. 2016 Mar-Jun;51(2-3):139-53
pubmed: 27015449
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychosom Med. 2004 Nov-Dec;66(6):938-42
pubmed: 15564361
Acta Psychiatr Scand. 2017 Oct;136(4):341-342
pubmed: 28865404
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
J Affect Disord. 2021 Feb 1;280(Pt B):1-6
pubmed: 33220632
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
J Affect Disord. 2020 Dec 1;277:510-514
pubmed: 32882508
Br J Psychiatry. 2004 Aug;185:127-33
pubmed: 15286063
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Psychother Psychosom. 2006;75(6):370-5
pubmed: 17053338
Depress Anxiety. 2012 Dec;29(12):1043-9
pubmed: 22933451
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Mar 20;38(3):192-195
pubmed: 32131151
Br J Psychiatry. 1997 May;170:479-82
pubmed: 9307701
J Interpers Violence. 2017 May;32(10):1501-1523
pubmed: 26056154
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
J Psychiatr Res. 2007 Jan-Feb;41(1-2):119-30
pubmed: 16460760
J Affect Disord. 2013 Apr 5;146(2):174-80
pubmed: 23098626
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Ann Gen Psychiatry. 2018 May 04;17:17
pubmed: 29755579
J Psychosom Res. 2008 Feb;64(2):177-83
pubmed: 18222131
J Trauma Stress. 2005 Oct;18(5):485-9
pubmed: 16281246
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
J Clin Psychol. 2018 Sep;74(9):1457-1484
pubmed: 29543336
Front Psychiatry. 2020 Dec 03;11:580736
pubmed: 33343419
J Trauma Stress. 2013 Jun;26(3):299-309
pubmed: 23696449
PLoS One. 2020 Oct 21;15(10):e0241032
pubmed: 33085716
Med Sci Monit. 2020 Apr 15;26:e924171
pubmed: 32291383
Compr Psychiatry. 2018 Nov;87:123-127
pubmed: 30343247
Int J Environ Res Public Health. 2020 Aug 26;17(17):
pubmed: 32858810
J Affect Disord. 2020 Nov 1;276:312-315
pubmed: 32871661
Psychiatry Res. 2020 Oct;292:113312
pubmed: 32717711
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030
Emerg Infect Dis. 2006 Dec;12(12):1924-32
pubmed: 17326946
Minerva Anestesiol. 2021 May;87(5):556-566
pubmed: 33432793
East Asian Arch Psychiatry. 2020 Mar;30(1):34
pubmed: 32229646
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Arch Gen Psychiatry. 1997 Jan;54(1):81-7
pubmed: 9006404
Br J Psychiatry. 2016 Apr;208(4):330-6
pubmed: 26892850
Asian J Psychiatr. 2020 Mar;49:101989
pubmed: 32143142
Depress Anxiety. 2009;26(12):1118-26
pubmed: 19918928
Soc Psychiatry Psychiatr Epidemiol. 2012 Jun;47(6):1001-11
pubmed: 21681455
Brain Behav Immun. 2020 Aug;88:916-919
pubmed: 32169498
J Affect Disord. 2016 Mar 15;193:267-73
pubmed: 26774513
Psychol Med. 2022 Jan;52(1):195-197
pubmed: 32456735
J Affect Disord. 2010 Jun;123(1-3):249-57
pubmed: 19765828
Acad Emerg Med. 2005 Apr;12(4):322-8
pubmed: 15805323
BMC Public Health. 2012 May 15;12:249
pubmed: 22455604
Psychiatry Res. 2021 Apr;298:113763
pubmed: 33545425
Prehosp Disaster Med. 2016 Dec;31(6):635-642
pubmed: 27641075
J Affect Disord. 2020 Nov 1;276:205-211
pubmed: 32697700
Ger Med Sci. 2020 Jun 22;18:Doc05
pubmed: 32595421
Prehosp Disaster Med. 2009 Sep-Oct;24(5):422-9
pubmed: 20066645
Epidemiol Infect. 2020 May 20;148:e98
pubmed: 32430088
J Affect Disord. 2021 Mar 1;282:527-538
pubmed: 33433382
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823737
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
J Affect Disord. 2021 Jan 1;278:365-371
pubmed: 33007626
J Affect Disord. 2020 Oct 1;275:48-57
pubmed: 32658823
J Affect Disord. 2021 Mar 1;282:9-17
pubmed: 33387746
Can J Psychiatry. 2009 May;54(5):302-11
pubmed: 19497162
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Am J Psychiatry. 2005 Mar;162(3):560-6
pubmed: 15741474
Psychol Bull. 2003 Jan;129(1):52-73
pubmed: 12555794
Lancet Psychiatry. 2020 Apr;7(4):e15-e16
pubmed: 32085839
Int Clin Psychopharmacol. 2016 Sep;31(5):249-58
pubmed: 26974213
J Affect Disord. 2021 Mar 15;283:123-129
pubmed: 33548905
J Trauma Stress. 2007 Aug;20(4):637-42
pubmed: 17721969

Auteurs

Claudia Carmassi (C)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Valerio Dell'Oste (V)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Electronic address: valerio.delloste@gmail.com.

Eric Bui (E)

Department of Psychiatry, Caen University and Caen University Hospital, Caen, France.

Claudia Foghi (C)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Carlo Antonio Bertelloni (CA)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Anna Rita Atti (AR)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Rodolfo Buselli (R)

Occupational Health Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Marco Di Paolo (M)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Arianna Goracci (A)

Department of Molecular and Developmental medicine, University of Siena, Siena, Italy.

Paolo Malacarne (P)

Anaesthesia and Intensive Care Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Maria Giulia Nanni (MG)

Department of Neurosciences and Rehabilitation, University of Ferrara, Ferrara, Italy.

Camilla Gesi (C)

Department of Mental Health and Addiction, ASST Fatebenefratelli-Sacco, Milan, Italy.

Giancarlo Cerveri (G)

Department of Mental Health and Addiction, ASST Lodi, Lodi, Italy.

Liliana Dell'Osso (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH